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Abstract
The Impact of Increased Collateral Flow on Transverse Arteriolar Microvascular
Tree Morphology
David Danzeiser
The goal of this study was to understand how arteriogenesis impacts
transverse arteriolar tree structure. The previous process involved a vascular
casting technique that utilized black India ink as the casting agent and manual
measurement of vessel morphology with ImageJ. This study decreased the
complexity of the casted samples by using a casting compound called Microfil.
Microfil’s viscosity can be adjusted and through experimentation, a viscosity was
found that stopped at the capillary level, allowing only the arterial side of the
circulation to be casted. A macro in ImageJ was written to help with
morphological measurement by bundling vessel length and diameter into one
measurement instead of two. These two adjustments were then used in a ligated
mouse model to compare healthy and remodeled vascular networks. The
analysis revealed that the only significant difference for length and diameter
measurements was in the diameters of the collateral. This indicates that it’s
possible that stimulating arteriogenesis in a clinical environment should not
cause any negative effects in the collateral-containing muscle. However, this
observation is potentially limited by the differences between the model and
patient.

iv

Acknowledgements

I would like to express my enormous gratitude to Dr. Trevor R. Cardinal for
all of his help, guidance and patience throughout this project. I would also like to
thank the other members of my thesis committee, Dr. Lily Laiho and Dr. Kristen
O’Halloran Cardinal, for contributing their valuable time and suggestions. Thanks
also to my fellow MATR lab members for the help and encouragement during my
project.
Thank you to John, Juanita, Sean, Emma and the late Gloria for being
such a great family. I will always be grateful that you have supported me not only
in this thesis but also with any of my endeavors. The constant encouragement
always provides the motivation to continue moving forward, always learning,
always improving.
To my friends: thank you for being a part of my life and for all the joy and
good times you have provided me.

“A master in the art of living draws no sharp distinction between his work and his
play; his labor and his leisure; his mind and his body; his education and his
recreation. He hardly knows which is which. He simply pursues his vision of
excellence through whatever he is doing, and leaves others to determine whether
he is working or playing. To himself, he always appears to be doing both.”
~Lawrence Pearsall Jacks

v

Table of Contents
List of Tables ................................................................................................... viii
List of Figures .................................................................................................... ix
Chapter 1 - Introduction ..................................................................................... 1
Normal Function of Circulatory System ............................................................. 1
Overview ........................................................................................................ 1
Microcirculation .............................................................................................. 4
Dysfunction in the Circulatory System ............................................................... 5
Peripheral Artery Disease .............................................................................. 5
Patient Treatment .......................................................................................... 8
Vascular Growth ................................................................................................ 9
Angiogenesis ............................................................................................... 10
Arteriogenesis .............................................................................................. 13
Conclusions of Vascular Growth .................................................................. 16
Attempts to Stimulate and Assess Vascular Growth .................................... 17
Objectives and Hypothesis .............................................................................. 20
Chapter 2 – Development of an Arterial-Specific Vascular Casting
Procedure .......................................................................................................... 22
Introduction ..................................................................................................... 22
Materials and Methods .................................................................................... 23
Results ............................................................................................................ 29
Discussion ....................................................................................................... 31
Chapter 3 – Development of an Image Morphometry Macro ........................ 37
Introduction ..................................................................................................... 37
Materials and Methods .................................................................................... 39
Design Criteria ............................................................................................. 39
Vessel Morphometry Procedure .................................................................. 40
Automation Validation .................................................................................. 41
Results ............................................................................................................ 42
Discussion ....................................................................................................... 43

vi

Chapter 4 – The Impact of Collateral Enlargement on Transverse Arteriolar
Tree Structure ................................................................................................... 48
Introduction ..................................................................................................... 48
Materials and Methods .................................................................................... 49
Ligation Surgery ........................................................................................... 49
Imaging ........................................................................................................ 51
Manual Measurement Using ImageJ ........................................................... 52
Statistical Analysis ....................................................................................... 53
Results ............................................................................................................ 54
Discussion ....................................................................................................... 57
Chapter 5 - Discussion ..................................................................................... 63
References ........................................................................................................ 67
Appendices ....................................................................................................... 72
Appendix A .................................................................................................. 72
Appendix B .................................................................................................. 76
Appendix C .................................................................................................. 77
Appendix D .................................................................................................. 78
Appendix E .................................................................................................. 80
Appendix F ................................................................................................... 81
Appendix G .................................................................................................. 85
Appendix H .................................................................................................. 87
Appendix I .................................................................................................... 88
Appendix J ................................................................................................... 89
Appendix K .................................................................................................. 91
Appendix L ................................................................................................... 92
Appendix M .................................................................................................. 93
Appendix N .................................................................................................. 94
Appendix O .................................................................................................. 95

vii

List of Tables
Table 1: Studies with Microfil casting compound ratios ...................................... 29
Table 2: Tabular comparison of Microfil versus India ink .................................... 33
Table 3: Automation validation results ................................................................ 41

viii

List of Figures
Figure 1: Basic circulatory patterns of blood flow ...............................................1vi
Figure 2: Human heart diagram ............................................................................ 2
Figure 3: Chronic limb ischemia ........................................................................... 6
Figure 4: Diagram of optimal circulation through angiogenesis .......................... 12
Figure 5: The process of arteriogenesis ............................................................. 15
Figure 6: Gracilis photomicrograph..................................................................... 24
Figure 7: Microfil casting procedure set up ......................................................... 25
Figure 8: Microfil casting procedure.................................................................... 28
Figure 9: Preliminary Microfil results ................................................................... 29
Figure 10: Initial Microfil viscosity adjustment results ......................................... 30
Figure 11: Successful vascular cast using Microfil ............................................. 30
Figure 12: Successful vascular cast using India ink ........................................... 31
Figure 13: Microfil penetration at capillary level .................................................. 32
Figure 14: How the automation program works .................................................. 40
Figure 15: Automation validation ........................................................................ 41
Figure 16: Macro versus manual measurement for length ................................. 43
Figure 17: Macro versus manual measurement for diameter ............................. 43
Figure 18: Automation macro on tortuous vessels .............................................. 44
Figure 19: Bright field microscopy setup ............................................................. 52
Figure 20: Strahler defined ordering ................................................................... 53
Figure 21: Successful vascular cast on ligated animal ....................................... 55
Figure 22: Sham versus control .......................................................................... 56

ix

Figure 23: Sham versus ligated .......................................................................... 57

x

Chapter 1 - Introduction
Normal Function of Circulatory System
Overview
The primary function of the circulation is to carry out nutrient and waste
exchange in all of the body tissues, and the rate of blood flow is controlled by
tissue demand for oxygen and nutrients. Additional functions include the
transport of endocrine factors, thermoregulation, and inflammation (17, 24, 32).
The blood flow and circulation in the body are divided into the systemic
circulation and the pulmonary circulation, the systemic circulation is also known
as the peripheral circulation (Figure 1) (17).

Figure 1 – Basic circulatory patterns of blood flow. Adapted
from (9).
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The pump that creates the circulatory flow is the heart. The human heart is
made up of 4 major chambers: the right atrium, right ventricle, left atrium and left
ventricle (17, 32). The heart also has 4 valves; each valve is unidirectional and
keeps blood in the heart flowing in the one direction. The valves are made up of
two or three small but strong flaps of connective tissue called leaflets. The
leaflets open to allow blood to flow through the valve and close to prevent blood
from flowing backwards (17, 32), depending on blood pressure gradients across
their location. The tricuspid valve is positioned between the right atrium and the
right ventricle. The pulmonic valve separates the right ventricle from the
pulmonary artery. The mitral valve is positioned between the left atrium and the
left ventricle and the aortic valve separates the left ventricle from the aorta
(Figure 2).

Figure 2: Human Heart Diagram, adapted from (21)
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The process of blood circulation begins with the right side of the heart
receiving blood that is low in oxygen from the vena cava, which drains veins from
all over the body. It then pumps the blood through the pulmonary arteries into the
lungs where it will become oxygenated. The oxygenated blood then leaves the
heart from the aorta and travels through a branching system of arteries and
arterioles; from the arterioles the blood travels into capillaries, the site of nutrient
and waste exchange, before moving into venules; the venules gradually coalesce
into veins, which bring the deoxygenated blood back to the vena cava and right
atrium to form a continuous circulation (3, 12, 17). At each order of branching,
the sizes of the vessels decrease but the number of individual vascular entities
increases (12, 17) and all blood in the human body will traverse the full circuit an
average of once each minute when the body is at rest and as many as six times
each minute during physically activity (17).
The role of the arteries is to transport blood under high pressure and
velocity to the tissues, compared to the veins, which transport blood at high
velocities but low pressures and thus form the capacitance vessels of the
circulation (as much as 60% of a person’s blood volume can be found in the
veins at rest). The arterioles are the last of the small branches of the arterial
system before blood flows into the capillaries (32), the primary site of nutrient and
waste exchange between the blood and the interstitium/parenchyma. The
venules then collect the blood from the capillaries as they gradually coalesce into
veins. Veins take the deoxygenated blood back to the heart to be oxygenated by
the lungs and also serve as a major reservoir of extra blood (17).
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Microcirculation
As stated earlier, the most important functions of the circulation occur in
the microcirculation. This is due to the fact that the microcirculation is the site of
nutrient and waste exchange. Capillary blood flow is determined at the upstream
arterioles, based on the contractile state of smooth muscle cells that encircle the
arterioles. Smooth muscle cells control arteriolar diameter by either contracting to
constrict arterioles and decrease blood flow, or relaxing to dilate the arterioles
and increase blood flow. Arterioles have the potential to drastically changing the
blood flow in response to tissue needs (17) because according to Poiseuille’s
Law, diameter is the largest contributing factor to blood flow:

, where F

is the rate of blood flow, P is the pressure difference between the ends of the
vessel, r is the radius of the vessel,  is the viscosity of the blood, and l is the
length of the vessel. It is important to note that blood flow is proportional to the
fourth power of the radius of the vessel, which is why it is the largest factor when
determining blood flow for the tissue for which it is supplying blood (17). The
arterioles will branch until they reach diameters of 5 to 9 micrometers where they
transition to capillaries (32). The walls of the capillaries are extremely thin,
constructed of single-layer, unicellular endothelial cells, which are surrounded by
a very thin basement membrane on the outside of the capillary (32). Although it
isn’t necessarily continuous like arteriolar smooth muscle, capillaries also have
perivascular cells that surround the endothelium, but do not contain smooth
muscle contractile proteins like arterioles (17, 32). The total thickness of the
capillary wall is only about 0.5 µm. The internal diameter of a capillary is 4 to 9
4

micrometers, barely large enough for red blood cells and white blood cells to
squeeze through (17, 32). Therefore, water, cell nutrients, and cell waste can all
interchange quickly and easily between the tissues and the circulating blood.
Diffusion is the most common way that substances are transferred between the
interstitial fluid. If a substance is lipid soluble, like oxygen and carbon dioxide, in
specialized microcirculations, such as the liver and kidney, it can diffuse directly
through the cell membranes of the capillary without having to go through the
pores. This process is much faster than for substances like sodium ions and
glucose that are lipid-insoluble and must diffuse through the inter-cellular
junctions or endothelial transport proteins (10, 17, 35). The human body has
about 10 billion capillaries with a total surface area estimated to be around 500 to
700 m2 with a total cross-sectional area of 2500 cm2, while the total crosssectional area of the aorta is only 2.5 cm2 (3, 17, 24). This is why branching plays
such a crucial role in efficient blood delivery; it allows the body to effectively
deliver crucial nutrients and expel harmful waste over a large area from a small
initial cross-sectional area.

Dysfunction in the Circulatory System
Peripheral Artery Disease
Ischemic vascular diseases are the most common cause of death in the
western world (19). The vascular endothelium is sensitive to changes in physical
forces (e.g. shear) or signaling molecules, both of which can result in pathology
(24).
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Peripheral arterial disease (PAD) is an obstructive arterial disease that
causes ischemia in the lower extremities during exercise or, in more severe
cases, during rest (46, 50). PAD is a highly prevalent atherosclerotic disease,
most common in aged populations (20, 46, 50), affecting 8 to 12 million
Americans. PAD is associated with significant morbidity and mortality (20, 50),
mostly due to a significant increase in coronary artery disease in these patients.
PAD can be categorized as either intermittent claudication, which involves pain
during physical activity, or critical limb ischemia, which involves a severe
blockage in the arteries of the lower extremities that results in pain at rest (20, 46,
50). Complications can include chronic ulcerations in the legs and feet and if left
untreated, the complications of critical limb ischemia will result in amputation of
the affected limb (Figure 3).

Figure 3 – Chronic limb ischemia. Adapted from (22).
6

The pathogenesis of PAD is due to atherosclerosis (17, 20, 32, 37, 46, 50).
Atherosclerosis is a disease of the medium and larger sized arteries in which
fatty lesions called atheromatous plaques develop on the endothelial surfaces of
the arterial wall (17, 32). Endothelial dysfunction is a precursor to atherosclerosis
and can be measured before plaques form. Endothelial dysfunction involves the
increased expression of adhesion molecules and a decrease in nitric oxide and
prostacyclin that normally prevent adhesion of platelets and monocytes (2, 17,
41). Circulating monocytes and lipids then aggregate at the site of the intimal
injury; eventually the monocytes extravasate and differentiate into macrophages
that phagocytose oxidized lipoproteins that have accumulated in the subintimal
space (2, 41). Ingestion of the lipoproteins by macrophages will lead to a fatty
streak and with time the fatty streak will grow larger and larger, which will cause
the surrounding smooth muscle and fibrous tissues to proliferate to form plaques
(2, 17). In addition, macrophages also release inflammatory cytokines that
stimulate smooth muscle cell proliferation and expansion of fibrous tissue in the
subintimal space (2, 41). The cellular proliferation coupled with the lipid deposits
can become so large that the plaque bulges into the lumen of the artery and
reduces blood flow; severe cases will completely occlude the vessel (17).
Normally, arteries are very elastic, but eventually atherosclerosis causes arteries
to become stiff, referred to as “hardening of the arteries,” due to connective
tissue accumulation and calcium salts precipitating with cholesterol and other
lipids causing hard calcifications (17). Once the arteries have hardened, the
plaques they contain are at risk for rupture; their rough surface also protrudes
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into the flowing blood, causing blood clots to develop that block the flow in the
artery (17, 32, 41). Patients with PAD have a much higher risk of coronary heart
disease; therefore the treatments aim to decrease cardiovascular risk while also
restoring the patient’s quality of life by reestablishing blood flow to the ischemic
limb (20, 46).

Patient Treatment
Most of the treatments for PAD are designed as secondary prevention for
cardiovascular risk. These treatments include: supervised exercise, smoking
cessation treatments for patients that are smokers, antiplatelet therapies, blood
glucose control for patients with diabetes, and lipid-lowering agents (20, 37, 46).
Other more serious treatments that address primary risk include percutaneous
coronary re-vascularizing interventions, coronary bypass surgeries,
endarterectomies, peripheral stenting and by-passing. In 1999, in the US alone,
there were 1.1million percutaneous coronary revascularizations, 355,000
coronary bypass surgeries and 131,000 endarterectomies (19). These serious
treatments have their limitations and risks, for example, not all patients with
coronary and peripheral vascular disease are able to receive these therapies due
to age or unavailability of a vessel for a bypass. Also, about one third of patients
will develop restenosis after treatment, and the neurological risk for patients that
need to be placed on cardiopulmonary bypass for their surgery is high (19).
While all of these treatments are somewhat successful they fail to stimulate the
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vasculature’s natural repair process of arteriogenesis and angiogenesis to
restore blood flow to the ischemic limb.
Therapeutic angiogenesis and therapeutic arteriogenesis were proposed
as treatment strategies in the early 1990s as an alternative to surgical or
endovascular revascularization therapies. The goal of therapeutic
angiogenesis/arteriogenesis is to treat ischemic disease by stimulating the
natural revascularization processes of the body. This would cause a restoration
of blood flow to an occluded tissue, which is an important but challenging goal as
there are several hemodynamic, metabolic as well as cellular and molecular
signaling factors involved in the mechanisms of structural remodeling and
adaptation in the microcirculation (24, 29, 30). The ultimate goal is to understand
the mechanisms of vascular growth in order to develop treatments to stimulate
arteriogenesis and angiogenesis as a single therapy or even as an addition to
other surgical procedures to achieve a more complete level of revascularization
for both macrovascular and microvascular diseases.

Vascular Growth
There are many different aspects to vascular growth, which can be
separated into three categories: vasculogenesis, angiogenesis and
arteriogenesis. Each of these aspects can then be broken down further into
different entities with different mechanisms, which will be discussed later.
Understanding each of these aspects is crucial for developing tests and testing
strategies that help create efficacious treatments.

9

Angiogenesis
Angiogenesis is defined as the growth and development of new capillaries
from existing capillaries and is a normal process critical to development, wound
healing, reproduction, and exercise adaptation (3, 12, 15, 19, 24, 38, 51). It is
also involved in inflammatory diseases such as rheumatoid arthritis, psoriasis,
and tumor growth (19). Angiogenesis is categorized by two different types of
vessel growth: sprouting angiogenesis and intussusceptive angiogenesis (12, 40).
In the embryo, the vascular system begins with vasculogenesis, the de novo
creation of capillaries by endothelial and perivascular cells. Vasculogenesis
(Figure 4A) is followed by a sprouting phase (Figure 4B) characterized by the
appearance of multiple capillary sprouts that then fuse to form the primary
capillary plexus (Figure 4C) that is remodeled into an optimal circulation by
intussusception (12, 13, 24, 40). In the adult, sprouting angiogenesis occurs
primarily in response to hypoxia while intussusception is stimulated by increased
shear stress (12, 13, 18, 40).
Intussusceptive angiogenesis involves the formation of new capillaries by
the development of tissue pillars in the capillary lumen and expansion of those
lumens to form new capillary networks (12, 38, 51). Further, both vascular growth
and remodeling occur mostly by intussusception (12, 13). The distinguishing
factor that separates sprouting angiogenesis and intussusceptive angiogenesis is
the formation of a tissue pillar into the vascular lumen. There are four
consecutive steps in pillar formation: first, a zone contact is established between
opposite capillary walls; second, there is a reorganization of the inter-endothelial
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cell junctions and central perforation of the bilayer; the third step is the formation
of the interstitial pillar core; and the final step is the increase in girth of the pillar
(3, 12). Intussusceptive angiogenesis is pervasive and can occur in many organs
during normal (cerebral vascularization after stroke) and pathological (tumor
angiogenesis) microvascular growth in order to establish normal branching
patterns (12, 38).
Once the pillar formation has occurred there are three distinct elements
that define intussusceptive angiogenesis. The first is intussusceptive
microvascular growth, which can be described as the expansion of the capillary
plexus (12). The next element is intussusceptive arborization, which is the
formation of a vascular feeding tree. The original capillary plexus formed by
vasculogenesis and sprouting doesn’t resemble a tree-like branching pattern,
where larger arteries branch into progressively smaller and smaller diameter
conduits, which is the most efficient flow delivery scheme. Intussusceptive
arborization is the process by which the capillary plexus is transformed into a
tree-like branching pattern after intussusceptive microvascular growth has taken
place. Intussusceptive arborization is initiated by the formation of compacted
vertical pillars; these pillars undergo reshaping into narrow tissue septa that
progressively fuse to delineate a new vascular entity (12).The final element is
intussusceptive branching remodeling, which is how the vascular tree geometry
is optimized (13). The function of intussusceptive branching remodeling is to
optimize hierarchy and flow properties within the system by minimizing power
consumption and maintaining a constant shear stress, this occurs by changes in
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branch angle through the formation of transluminal pillars near bifurcation sites of
arteries and veins (13). Another aspect of intussusceptive branch remodeling is
the removal of branches that are unnecessary by a mechanism called vascular
pruning, or regression (38), where large numbers of smaller vessels are reduced
for few larger sized ones (Figure 4D) (4, 12, 13). The cause of pruning can be
attributed to hyperoxia, which causes VEGF to be down-regulated and
unnecessary vessels to be pruned (38).

A

C
B

D

Figure 4 – Diagram of optimal circulation through angiogenesis. A)
Vasculogenesis is the creation of capillaries by endothelial and perivascular
cells. B) Sprouting marks the appearance of multiple capillary sprouts that then
fuse to form the C) primary capillary plexus. Intussusceptive angiogenesis then
begins with intussusceptive microvascular growth (IMG), or the rapid
expansion of the capillary plexus. Next, intussusceptive arborization (IAR)
forms the vascular feeding tree. Finally, intussusceptive branching remodeling
(IBR) optimizes branching geometry through branch angle adjustments and D)
pruning.
12

The effectiveness of pillar formation is dependent on blood flow rate, and
the faster the blood flow rate is, the faster the pillar will form, and it is a process
that occurs with minimal amounts of endothelial cell proliferation, while also
maintaining low vascular permeability. In contrast, sprouting angiogenesis is a
drawn out process that requires extensive proliferation of endothelial cells and an
increased vascular permeability , which expends more energy (12).

Arteriogenesis
Angiogenesis is the formation of new capillaries by sprouting and
intussusception from pre-existing architecture, and vasculogenesis is the
embryonic development of blood vessels from angioblasts (4). Arteriogenesis, on
the other hand, is a different process by which a small arteriole chronically
increases its diameter through outward remodeling (4, 38). Angiogenesis and
arteriogenesis have different initial pathways as well as different results; the main
difference is that arteriogenesis is more effective than angiogenesis in replacing
an occluded artery by returning normal blood flow to an ischemic tissue (4). The
outward remodeling occurs through endothelial cell activation, vascular cell
proliferation, and rearrangement of the extracellular matrix (38).
Increased sheer stress is a trigger for increases in arterial diameter (flow
induced dilation), and with the change in flow that persists, outward remodeling
of the arterial wall will occur to normalize hemodynamic shear stress (4, 19, 38).
It makes sense then, that the maximal arteriogenesis occurs in situations at
maximal sheer stress (4). The increased flow increases the arterial wall tension
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and activates the endothelium (4). What is still unclear is how the increase of
sheer stress is being “sensed” by the cells of the vascular wall (4, 19). The
endothelium play a crucial role in the remodeling response to sheer stress as the
first sign of arteriogenesis after arterial occlusion is that the endothelial cells of
collateral vessels appear swollen and are randomly oriented and do not line up in
the direction of blood flow (4). Endothelial cells are able to react to different sheer
stress gradients by activating multiple transcription factors (19). Once the
endothelium is activated, there is an increase in endothelial nitric oxide (NO)
synthase, monocyte chemoattractant protein (MCP-1), transforming growth factor
beta (TGF-β), as well as intercellular adhesion molecule-1 (ICAM-1) and vascular
cell adhesion molecule (VCAM) (4, 19, 43). The up-regulation of MCP-1 seems
to be important for the attraction of monocytes to the endothelium and their
aggregation around growing collateral vessels (4, 19). The effects of NO are not
yet understood, but it has been found to dilate collateral vessels, which
decreases shear stress. NO can also activate metalloproteinases (MMPs) and
may play a role in cell migration and proliferation, on the other hand, NO can also
have inhibitory effects on endothelial, vascular smooth muscle cells (VSMC),
atherogenesis, and inflammation (19). There is also an increased permeability of
the endothelium, as can be seen from the adherence of monocytes, and leakage
of platelets, plasma proteins and erythrocytes (4, 42). Other molecules that have
been found to be involved are MMP-2, FAK, and bone marrow tyrosine kinase (4),
which are involved in cell proliferation and migration (4).
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Increased shear stress also changes VSMC during arteriogenesis by
converting smooth muscle cells (SMC) between contractile (physiological
phenotype) and synthetic (proliferative phenotype) (4, 47). The cellular signals to
mobilize the SMC come from the degradation of the basement membrane, and
the internal and external elastic laminas, which act as barriers to prevent outward
remodeling of the vessel. In order for this degradation to occur MMP-2 and MMP9 are up-regulated in the SMC, which causes the basement membrane and the
internal and external elastic laminas to become fragmented to allow for collateral
vessel growth (4). Other signals come from transcriptional regulators like ERK
and FAK, which promote cellular migration (4). The mechanical strain from the
occlusion, increased sheer stress and growth factor stimulation lead to the
autophosphorylation of FAK and ERK to promote the migration and proliferation
of VSMC so that arterioles’ successfully transform into collateral vessels (Figure
5) (4).

Figure 5 – The process of arteriogenesis. Adapted from (38).
15

It is important to appreciate that arteriogenesis is more effective than
angiogenesis in replacing an occluded artery by returning normal blood flow to an
ischemic tissue (4) and understanding the entire process is crucial to advancing
the field of therapeutic arteriogenesis for diseases like PAD.

Conclusion of Vascular Growth
All of the remodeling processes are a result of complex and coordinated
cellular interactions that are brought about by cell-to-cell and cell-to-matrix
communication from environmental stimuli, so that constant blood vessel
remodeling occurs (38), where network structure is remodeled to match tissue
requirements . Understanding how vascular growth works and how different
therapies affect the long-term stability and survival of tissue in patients with
ischemic diseases is critical to designing both revascularization therapies for
ischemic disease (and anti-angiogenic therapies for cancer) (38, 51). As we
progress in therapeutic arteriogenesis and angiogenesis there are important
considerations that need to be made: delivery methods and agents need to be
effective in stimulating arteriogenesis but also have acceptable levels of risk, e.g.
plaque instability, plaque growth, or an inflammatory response. We must weigh
success from our vascular growth treatments with treatment failure from tumor
growth or other inflammatory diseases, and decide how much of that risk is
acceptable when searching for success (19). As we move forward and continue
to gain insight into vascular growth and the role that it plays in other diseases,
there is the potential that this type or research could change the face of medicine
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in the next decades, with more than 500 million people worldwide predicted to
benefit from pro or anti-angiogenesis treatments (15).

Attempts to Stimulate and Assess Vascular Growth
It is important in the development of treatments that we are able to both
stimulate and assess vascular growth. With this goal come many challenges as
we make progress toward developing vessel maturation therapies for therapeutic
angiogenesis. One hope for patients who are suffering with various ischemic
diseases is the ability to form vascular networks in vivo by delivering angiogenic
or arteriogenic molecules as recombinant proteins using controlled-release
devices or as genes using viral vectors or plasmid DNA (23). Results from clinical
trials using these techniques have shown that the formation of a mature vascular
network will require very precise regulation of a large number of both angiogenic
stimulators and inhibitors (24). For example, clinical trials for limb ischemia using
VEGF and FGF yielded less than optimal results, as some patients had
successful limb salvage while a majority of the patients treated with VEGF
developed transient limb edema, which is consistent with VEGF enhancement of
vascular permeability (1). Preclinical experiments using a controlled release
device or an adenoviral vector to deliver basic FGF or VEGF led to the transient
development of stable vascular networks, which after time began to resemble an
immature tumor vasculature (11, 36). Therefore, more precise understanding of
the vascular growth process through the use of animal models is necessary
before therapeutic angiogenesis will be successful.
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Many follow up experiments have focused on a more precise approach as
the lack of positive trial data has focused researchers and clinicians on the fact
that arteriogenesis and angiogenesis are complex processes and simply
supplying vascular growth factors to ischemic tissue does not provide effective
therapy (49).
One approach to improve the effectiveness of therapeutic angiogenesis is
to deliver a cocktail of angiogenic molecules to the desired site in a
spatiotemporal manner that more accurately resembles their endogenous
production (24). Polymeric delivery systems can mimic the endogenous release
of two or more growth factors. For example, controlling the dose and rate of
delivery for a VEGF and platelet-derived growth factor (PDGF) combination
therapy leads to vessels that appear more mature than those formed using
VEGF alone (39). These results moved researchers to find out the minimal
number and type of molecules needed to produce stable vascular expansion and
to figure out how to optimize delivery in order to effectively treat ischemic disease.
Another approach is to deliver a transcription or growth factor that regulates
expression of the various growth factors required for mature vessel formation.
Hypoxia-inducible factor (HIF)-1α is responsible for regulating the expression of a
large number of pro- and antiangiogenic genes and it enhanced perfusion in an
ischemic rabbit hind-limb model (45, 48).
To be truly effective, once mature vessels have been established,
therapeutic angiogenesis must successfully create a mature network structure. A
mature network involves network remodeling and vascular reactivity. Network
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remodeling involves arborization and pruning to create an efficient network (12,
31), while vascular reactivity is important for regulating blood flow in response to
tissue needs (26). The ultimate goal of therapeutic angiogenesis is to
revascularize ischemic tissue, which requires a mature vasculature and a mature
network that will restore tissue oxygenation levels in response to the chronically
insufficient blood supply.
The therapies described above are moving towards creating more mature
vessels but little work is being done to create more mature networks, which is
due to the difficulty of assessing a network. Most often, network maturation is
assessed by counting vessels in a histological cross section, which gives little
information on what the overall network looks like. In order to create more
effective therapies it’s important to understand how to create more mature
networks.
Several morphological parameters such as the diameters of blood vessels,
blood path length, vessel length, branching characteristics, and vessel quantity
within a vascular network describe the architecture of the microcirculation.
Following ischemia, these morphological parameters change. Diameters
increase in response to the elevated shear stress, blood path length increases as
blood is re-routed, which consequently causes a change in the branching
characteristics of the network because of the structural remodeling and changes
in flow direction. All of these changes could be important when developing
therapies; however, researchers in this area typically ignore network topology.
Instead of focusing on one morphological parameter, such as vessel number, it
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would be beneficial to examine as many as possible in order to evaluate the
vascular network as a whole. The microcirculation is critical to nutrient and waste
exchange and changes could affect muscle functionality; the overall goal of this
research was the changes in morphological parameters following arterial
occlusion.

Objectives/Hypothesis
Currently, our lab uses a manual process to gather morphological data for
our experiments. The morphological data is used in a model to predict
hemodynamics and calculate vascular morphometry in normal and remodeled
microcirculatory networks. This study aims to establish a system that will
expedite the process of gathering morphological data needed for the model and
to examine the impact of arterial occlusion on morphology. More specifically, this
study had three distinct objectives to reach the goal:
(1) Create a vascular casting protocol to only cast the arterial side of the
microcirculation. Previous work filled both the arterial and venous sides,
even though only the arterial side was measured. The venous fill
increased the difficulty of measurement and tracing and provided no
additional value to the research.
(2) Decrease the amount of time it takes to measure the microvasculature of
the anterior gracilis muscle through some form of automation. Previous
work used completely manual measurements to gather data and I sought
to expedite this data-gathering process.
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(3) Determine the effects of elevated flow in a collateral artery on branching
arteriolar network topology. This aim utilizes the proposed methods to
demonstrate proof-of-concept and to determine if collateral remodeling
was associated with remodeling in the arteriolar side branch trees.
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Chapter 2 – Development of an Arterial-Specific Vascular Casting
Procedure
Introduction
Efficient morphological assessment requires a multi-step tissue
preparation process in order to collect data for analysis and for input into our
model. The process of sample preparation can be summarized in 5 steps:
vascular casting, dissection, dehydration, clearance, and sample mounting.
Improving the vascular casting protocol could optimize the entire process of
gathering data for the model. The goal of vascular casting is to fill the circulation
with a high contrast agent, which generally requires clearing the circulation of
blood. The original protocol for vascular casting utilized nontoxic India ink(16).
Although this protocol is successful in achieving high contrast between the
vasculature and surrounding tissue, there are some drawbacks to casting with
India ink and the subsequent morphological analysis, which include: India ink
remains in a liquid state, so leakage occurs if the vessels aren’t cauterized
properly during muscle dissection; India ink takes a significant amount of time to
dialyze, filter, and purify in preparation for injection; and India ink casts both the
arterial and venous side of the circulation. I aimed to resolve these three issues
to improve data collection. The solutions formulated for visualizing only the
arterial side were to increase the viscosity of the casting agent to prevent it from
traversing the capillary level by adding dextran to the casting compound or to use
a fluorescent marker to label the arterial side of the circulation, so that when
imaged the arterial side is expressed with fluorescence. While researching
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different casting agents, I found a group that was able to successfully cast the
spinotrapezius vasculature of a rat using Microfil (27). Further research into
Microfil demonstrated that it was a radiopaque, polymerizing silicone rubber
compound with variable viscosities that could be used to cast the arterial side of
both a rat and mouse kidney (33). This previous work was successful using
Microfil to cast the arterial side and led me to begin protocol modification with
Microfil instead of modifying the India ink or using fluorescence.

Materials and Methods
Microfil is a casting agent with variable viscosity, composed of a colored
compound, diluent, and curing agent. The optimal Microfil viscosity for arterial
casting of the gracilis muscle was investigated using a murine model. All
protocols were approved by the Institutional Animal Care and use Committee.
Male Swiss Webster mice weighing 25-35g from the California Polytechnic State
University Vivarium were used to optimize the Microfil casting protocol, 8 male
C57BL/6 mice were used to validate the consistency of the protocol, and another
8 male C57BL/6 mice were used to assess the impact of arterial ligation on
microvascular morphology (presented in Chapter 4).
The longitudinal gracilis arcade is the main blood supply for the gracilis
muscle, and is fed by the profunda femoris of the femoral artery (medial side)
and the saphenous artery (lateral side) (16). The gracilis arcade runs parallel to
the muscle fibers over almost the entire length of the muscle (16) (Figure 6).
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Figure 6 – The gracilis artery runs through the gracilis anterior
and is fed by the profunda femoris and the saphenous artery.
Completing a vascular cast with Microfil requires the preparation of
surgical instruments and materials. These included forceps, bone-cutting
scissors, iris scissors, hemostats, microdissection scissors, a vascular clamp,
surgical tape, 20ml syringe, bench cover, heating pad, catheter/stopcock/blunt
needle apparatus containing a PE-100 catheter, isoflurane anesthetic, and gauze
sponges (Figure 7). A vasodilator cocktail is also necessary to flush out the
blood and maximally dilate the vasculature before injecting the casting agent.
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Figure 7 – Microfil casting procedure set up. A) Light microscope, which can be
rotated in to check on the progress of the vascular cast. B) Surgical instruments –
Hemostats (1), Bone scissors (1), metzenbaum scissors (1), Iris scissors (1), forceps
(2), microdissection scissors (1), vascular clamp (1). C) Syringe pump. D) Bench
Cover with heating pad underneath. E) Octopus light source. F) Isoflurane nose cone.
G) PE-100 catheter. H) Miscellaneous items-Saline, gauze, tape.

The cocktail consists of heparin, adenosine and sodium nitroprusside, which are
all combined with PBS solution and heated to 37°C in a water bath. The Microfil
mixture is created by vortexing 2mL MV-122, 1.25mL HV-Diluent and 1.25mL
MV-Diluent into a 14mL conical and placing in the 37°C water bath (Figure 8A).
Once the prep work was done the animal was weighed and anesthetized with
isoflurane and laid supine upon a heating pad to maintain core body temperature.
Hindlimb hair was removed with clippers and depilatory cream (Figure 8B). The
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animal was taped down to the heated bench cover and the skin was separated
from the superficial abdominal and thoracic musculature. Once the skin was
removed, the 20mL syringe was filled with warm vasodilator cocktail, loaded into
the syringe pump, and attached to the catheter. An incision was made through
the abdomen, close to the diaphragm before the ribs and diaphragm were quickly
transected and reflected with hemostats to expose the chest cavity (Figure 8E).
Due to pneumothorax, the ventricular catheterization must be done quickly
before blood begins clotting, which would ruin the clearance and vascular cast.
Excess tissue was cut away from around the heart and a small incision was
made in the apex of the left ventricle. The catheter was inserted through the
incision into the left ventricle and clamped in place with a vascular clamp (Figure
8C). Once the catheter was in place the right atrium was cut and the syringe
pump was started in order to inject the vasodilator cocktail at 5ml·min -1. The skin
above the gracilis muscle was removed to visualize vascular clearance before
refilling the 20mL syringe to continue flushing the vasculature (Figure 8G). Once
the entire vasodilator cocktail had been injected, .2mL of curing agent was added
to the Microfil mixture to start the polymerizing reaction (it is crucial to wait until
the last possible moment to add the curing agent when preparing the Microfil
mixture to maintain the compound in a liquid state during perfusion). The Microfil
mixture was inserted into the syringe pump and perfused at .5mL per minute
(Figure 8D). The hindlimb was monitored under the microscope until the Microfil
had passed the knee. At this point the syringe pump was stopped (approximately
1mL of Microfil had been perfused) and a tourniquet was tied around both ankles
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with silk suture to prevent entry of the Microfil in the venous circulation through AV shunts near the ankle (Figure 8F). The Microfil perfusion was resumed, and
continued until the casting agent spilled out of the right atrium or until the cast
was deemed satisfactory by visual inspecting the gracilis under the microscope.
The catheter was removed, but the heart clamp was left to prevent any Microfil
leakage, and the mouse was allowed to sit undisturbed for at least 10 minutes
while the Microfil begin curing (Figure 8H). The open wounds were covered with
plastic wrap and the mouse was placed in a plastic bag to prevent desiccation
while the animal was left overnight at room temperature to allow the Microfil to
cure completely (Appendix B).
Following the overnight curing period, the gracilis muscles from both limbs
were carefully dissected and gently placed between two cover slips to maintain in
situ orientation during the dehydration process. The muscles were dehydrated by
a graded series of ethanol solutions (25, 50, 75, 95 and 100%) for at least 12
hours for each alcohol dilution. Following dehydration the muscles were placed
into 100% methyl salicylate for clearance (16). Once cleared, the muscle was
oriented correctly, placed onto a slide, covered with permount, coversliped, and
given 48 hours to dry before imaging. See Chapter 4 materials and methods for
imaging.
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Figure 8 – A) Microfil cast ingredients (from left to right) MV-Diluent, HV-Diluent,
MV-112, Curing agent. B) In order to prep the animal the hindlimbs were trimmed
with clippers and then the hair was removed completely with depilatory cream to
minimize hair contamination in the sample. C) An incision was cut in the apex of the
heart and PE-100 catheter tubing was inserted into the apex and clamped into place
with a vascular clamp. D) Following clearance the 20mL syringe was loaded with the
Microfil cocktail for perfusion. E) In order to gain access to the heart the ribs and
diaphragm were quickly cut through and clamped back with hemostats in order to
open the chest cavity. F) Ankle ligation to prevent Microfil from casting the venous
side through A-V shunts. G) Proper clearance of the gracilis muscle was checked
before Microfil was perfused. H) After Microfil perfusion gracilis was checked to
make sure perfusion penetration was adequate and that there was no venous
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Results
Achieving the desired results required two different studies with multiple
experiments. Preliminary testing of the Microfil yielded poor results (Figure 9).
Further experimentation adjusting the viscosities by varying the amount of MV122 and HV-Diluent (Table 1 – Study 1) also provided poor results (Figure 10).
For study 2, the ratios of diluent and MV-122 were kept at a constant 5:4 ratio,

Figure 9 – Preliminary Microfil yielded poor results as the
filling is incomplete and spotty. This sample is of the right
anterior near the saphenous artery.
Study 1

Study 2

Table 1 – Studies with Microfil casting compound ratios. Study 1 was
unsuccessful as adjusting the ratios between the MV-122 and Diluent
ruins the compound. Study 2 was successful; it maintains the 5:4 ratio of
Diluent to MV-122 while also varying the viscosity. Ultimately,
experiment 2 of study 2 provided the wanted results.
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while the viscosity was adjusted by mixing MV-diluent with HV-Diluent (Table 1 –
Study 2). Experiment 2 provided the desired results: solid casting with no
bubbles, which only penetrated to the capillary level (Figure 11).

Figure 10 – A) Poor results from the left anterior of study 1-experiment 1 near
the saphenous artery. B) Poor results from the left anterior of study 1experiment 5 in the center of the gracilis muscle.

Figure 11 – Control animal B. A) Left leg anterior gracilis. B) Right leg
anterior gracilis.
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Discussion
Results from the new Microfil casting procedure were a great improvement
over previous India ink vascular casts. Figure 12 displays a successful India ink
fill of the anterior gracilis. From Figure 12, it is clear that both the arterial and
venous side of the circulation is filled. The India ink completely fills the arterial
side, the capillaries (which look like strands of hair in the image) and then the

Figure 12 – A successful India ink fill casts both the arterial
and venous side of the vascular system.
venous side. In order to use this sample for measurement one must visually
isolate the arterial side from the venous side before proceeding. The interest for
our lab lies in the arterial side of the circulation because that’s where blood flow
is determined and where vascular remodeling predominantly occurs following an
occlusion (19); the venous side cast just adds confusion during morphology
measurement. Although it is possible to discern arterial from venous by looking at
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relative size of the vessels (the venous side is larger than the arterial side)
mistakes are still made and often smaller arterial trees are missed due to the
complexity of the images. Arteries and veins run parallel to each other and
intertwine along their paths, causing difficulties when trying to differentiate
between the two. The whole process would be easier if the vascular side wasn’t
casted. My final Microfil vascular casts (Figure 11) show that it is possible to cast
the arterial side of the anterior gracilis using a ventricular catheterization. It is
clear from Figure 13 that the Microfil penetrates right up to the capillaries on the
arterial side and then stops. Further, only the arterial side of the saphenous and
profunda femoris is filled, which indicates that no Microfil was able to transition to
the venous side through the A-V shunts in the lower leg.
As stated earlier, Microfil is a polymerizing silicone rubber compound that
comes in three parts that must be mixed to create the injectable compound. This

Figure 13 – Magnification of Figure 11A to show penetration of Microfil at
capillary level.
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eliminates the other issues encountered with India ink as once Microfil has cured,
it will not leak and the preparation involved is more straight-forward, requiring
only mixing without the need to dialyze, filter, and purify (Table 2). All of the
control Microfil samples can be found in Appendix A. It is important to note that

Table 2 – Tabular comparison of Microfil versus India ink
although the same protocol was followed for every vascular cast, there are still
variable results in the samples. This is likely due to the variability of catheter
placement into the apex of the left ventricle during the ventricular catheterization.
There is a very limited window of time to correctly cut the apex of the heart and
clamp the catheter in place. If it is placed incorrectly it is difficult to shut off the
syringe pump and reposition the catheter without damaging the tissue. There is
also a risk of blood clotting, which will impede blood clearance and penetration of
the casting agent into all arterial branches of the vasculature. Poor catheter
position, damaged heart tissue, and blood clotting can all be factors that
determine a good cast from a poor cast (Appendix A – replicate A versus
replicate B).
To develop the Microfil casting protocol I began with a 4:5 ratio of Microfil
MV-122 and HV-Diluent (Figure 8A), which was then catalyzed with 5% by
volume of the curing agent. These values were taken from the Microfil manual
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and also used by Lash and Marxen in their research groups (27, 33). Using these
values I began my preliminary ventricular catheterizations and the results (Figure
9) were poor, showing incomplete and spotty filling. The initial conclusion was
that the poor casting was due to an error in technique with the ventricular
catheterizations, so more India ink casts were performed to compare to previous
results. Once correct technique was established, more Microfil casts were
performed with similar results. Efforts were then focused on varying the flow rate
to achieve the desired results; the idea being that if the Microfil was too viscous,
increase the force of injection. The flow rate was raised to 5ml/min (ink fills were
performed at 3ml/min), with more poor results; any higher rate resulted in a
pressure build-up that would cause the syringe pump to malfunction and
sometimes catheter ejection from the heart. The next modification was to
decrease the viscosity of the Microfil cocktail by adding less of the HV-Diluent
and more MV-122. I experimented with a change in the HV-diluent to dye ratio in
order to vary the viscosities and find a mixture that would allow for maximum
penetration while also preventing venous return (Table 1); however, this
approach yielded poor results, (Figure 10). The conclusion was that although the
viscosities of the mixtures were different, the ideal ratio between the mixtures
was changing and, therefore, the Microfil was unable to mix properly when
vortexed, which yielded poor vascular casts.
A batch of the normal viscosity diluent—MV-Diluent, was ordered and
used to mix with the high-viscosity diluent in a new attempt to alter the viscosity,
while also still preserving the necessary ratios. This approach was markedly
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more successful, which led to discovering the best mixture for maximum arterial
penetration and minimal venous return during vascular casting (Figure 11).
However, although the Microfil was stopping at the capillary level, it was still not
viscous enough to be stopped at the artery level and so the Microfil would
perfuse down into the lower leg and across the A-V shunts. This could be seen
under the microscope as the Microfil would stop at the capillaries of the gracilis
but would still return on the venous side of the femoral and saphenous arteries,
causing backfill into the venous circulation of the gracilis. The solution to this
problem was to tie a tourniquet around the ankle of the mouse to prevent the
Microfil from entering the a-v shunt (Figure 8F). This was successful, with slight
modification. Initially the tourniquets were tied after the vasodilator cocktail but
before the Microfil, which caused a build-up of fluid pressure in the lower leg.
This pressure build-up led to a reversal of the pressure gradient when the syringe
pump was stopped and caused the Microfil to be pushed back and un-fill the
artery. This problem was addressed by starting the Microfil casting with no
tourniquet on the ankle and applying the tourniquet a few second after the
Microfil passed the tourniquet site on the ankle. At this point the Microfil flow rate
had been lowered to .5ml per minute. This decrease allowed for easier
visualization under the microscope as well as providing ample time to perform
the tourniquets.
Multiple variations of Microfil were tested before the ideal viscosity
(keeping the ratio between diluent and MV-122 constant) was found. Even then,
protocol adjustments needed to be made to accommodate the venous filling from
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the a-v shunts. It is also important to note that the India ink casting protocol
perfused 5ml of ink, even though a mouse only has ~2ml of blood volume. I had
much better results when setting the pump to only deliver 1ml and visually
inspecting the casting progress in the gracilis muscle. If the cast was complete,
the Microfil perfusion was stopped. If the cast was incomplete, the pump was
continued until adequate casting had been achieved. Performing vascular casts
with Microfil was successful and future work in this area could test varying the
ratios of the different diluents depending on the research needed. The new
protocol calls for a 50/50 mixture of high-viscosity and normal viscosity diluent for
the results shown. However, if further penetration of the capillaries or less
penetration of the arterioles was desired, a lower or higher viscosity Microfil
cocktail may be necessary, respectively.
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Chapter 3 – Development of an Image Morphometry Macro
Introduction
Once the casted tissue is prepared (chapter 1) and imaged (chapter 4),
morphological analysis is necessary. Important morphological parameters
include: vessel length, vessel diameter, branch angle, vessel order, and vessel
quantity. To manually measure these features is a laborious task; this entire
project consisted of 32 samples requiring morphological analysis, with the
samples averaging around 1000 vessels per sample (Appendix H). The first step
in the morphological analysis is to order each vessel in each sample, followed by
each morphological measurement. So, to obtain data on length, diameter, and
branch angle requires 96,000 measurements, plus the time it takes to order each
sample. The other issue with manual measurement is the variability in human
measurement. Any type of automation or efficiency brought to this process that
could decrease time and/or increase the consistency with measurement would
be beneficial.
The general challenge with automatic determinations of vessel
architecture is determining “vessel” from “non-vessel”. An algorithm needs to be
written and “trained” with numerous samples. Then the vascular system can be
broken up into individual segments and functions can be written to consistently
measure the different morphology.
Two areas where automatic measurement and image analysis are being
pursued are ophthalmology and neuroscience—where the morphology of retinal
blood vessels and neuron axons, respectively, are important (5, 8). Interest in

37

measuring retinal vessel architecture stems from the fact that it is non-invasive
and has been correlated with cardiovascular and cerebrovascular disease (8, 28).
Retinal vessel measurement faces similar issues as our lab with manual
quantification and measurements being slow and biased by the observer (8).
Algorithms can be used to automatically determine arteriolar diameters (8) by
fitting a vessel intensity profile to a double Gaussain function by non-linear
regression, and using an edge detection algorithm. This model, created by Sobel,
involves using a sliding linear regression filter to determine points of maximum
intensity variation to determine “vessel” from “non-vessel” (8). Sophisticated
algorithms require many samples to be tested in order to become more precise
with each iteration. Chapman’s group found that even their most consistent and
repeatable algorithms yielded measurements significantly greater than manual
measurements (8). Even though the results between automatic and manual were
different, there is still value in the consistency with which an automated program
can make measurements. Ideally, a full automation strategy would be designed
to acquire the necessary morphology measurements, however, due to the skillset
and amount of samples necessary, a different avenue from full automation was
pursued.
Our interest in microvascular topology requires manual measurements of
diameter, length, branch angles, vessel order, and vessel quantity for input into a
computational model for calculating hemodynamic conditions. Each of these
morphology measurements must be evaluated in hundreds of vessels using
morphometry software, such as ImageJ. This effort requires tracing thousands of
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vessels manually, plus drawing the length and diameter of segments to obtain
each of the morphological measurements; this process requires considerable
time, even for those experienced with the technique—to order and measure the
lengths and diameters of a sample would take about 2-3 hours, depending on the
number of vessels. The goal for this portion of the research was to improve the
efficiency of the manual tracing by developing a process to semi-automate the
morphological analysis by combining the diameter and length measurements into
one process instead of two.

Materials and Methods
Design Criteria
One of the goals of this thesis was to increase the efficiency of the morphology
measurements. One of the inefficiencies I pinpointed was in the manual data
collection. Ideally, a fully automated data collection program would solve this
issue. However, full automation was not only outside of my skillset, but also
would require approximately 100 samples to distinguish “vessel” from “notvessel”; so instead, I opted to simplify the problem significantly. The objective for
this aim of the thesis was to gather two diameter measurements and two length
measurements, average the diameters and lengths independently, and record
both the length and diameter of a vessel when the user defined the vessel with 4
mouse clicks. This, theoretically, would save time (since the user doesn’t have to
measure the diameter and length separately), while also being a suitable
replacement for manual measurement by outputting similar results or even
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increasing the accuracy of the data collected (since two diameter/length
measurements would be averaged, instead of making one measurement).

Vessel Morphometry Procedure
The automation program was written using ImageJ and the macro editor.
To reiterate, the goal for the program was to calculate the length and diameter of
a vessel by drawing a quadrilateral to approximate the shape of the vessel
segment (Figure 14). This is accomplished with four user-defined points, which
create the quadrilateral and then output an average vessel diameter (based on
the average of H1-3 and 2-4) and vessel length (L1-2 and 3-4) (Figure 14). To define a
vessel, 4 points are indicated to outline the vessel by hovering the mouse over
each point and selecting the “a” key. The points must be selected in the correct
order or the program will output incorrect measurements. Any mistakes can be
reversed by selecting “y” to erase the previous selections. From the 4-points, the

Figure 14 – General idea for how the automation program would work. The user
would click the 4 points in order to identify a given vessel; the program would
then draw a quadrilateral and measure the length and breadth by averaging the
distance between 1-2 and 3-4 and the average distance between 1-3 and 2-4,
respectively.
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macro creates a quadrilateral, whose length and height dimensions are
automatically calculated and output into an ImageJ log file, which can be saved
and exported into Excel (Appendix D). The code used to carry out these
measurements can be found in Appendix C.

Automation Validation
As a simple test to test my macro, I drew 3 rectangles (Figure 15) and
measured them manually and with the macro in ImageJ. The results (Table 3)
show that the macro is calibrated (calibration is built into the macro so recalibration for every image is unnecessary—see manual protocol in Appendix L),
measuring correctly (Table 3) and ready to be tested with a more robust

Figure 15 – 3 rectangles measured manually and with the macro to
test functionality.

Table 3 – Automation validation results
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comparison on vascular casted samples. Next, four gracilis muscle samples were
chosen (ECLNI, ECRNI, FCLNI and FCRNI) and were measured with the macro
and manually to examine the accuracy of the program when measuring blood
vessels instead of rectangles. Those four samples were chosen because they
had the highest number of blood vessels, which would yield a more powerful
comparison.
JMP was used for the statistical analysis to determine if the macro could
substitute for manual measurement of lengths and diameters. Because there
were multiple orders and therefore multiple measurements per sample a
repeated measures analysis was performed; statistical significance (p<0.05)
between each condition was assessed using the Tukey-Kramer test, and a block
was placed on the mouse to eliminate mouse-to-mouse variability within the
results (Appendix E).

Results
The macro-obtained measurements were compared to the manually
obtained measurements to examine if the macro could be used as an acceptable
substitute to manual measurement. Average lengths and diameters from
samples ECLNI, ECRNI, FCLNI and FCRNI were used to calculate the least
square means for each order and then the least square means were compared
for each order. The results show no significant difference between macro and
manual measurement except between order 5 length values (Figure 16 and 17).
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Figure 16 – Macro versus manual measurements for length showed a
significant difference for order 5 vessels.

Figure 17 – Macro versus Manual measurements for diameter showed no
significant differences.

Discussion
The results showed that that the only significant difference between the
macro and manual measurement came from measuring order 5 lengths. The
reason for this difference stems from the way that the macro is estimating values.
When a vessel is straight (Figure 14) using a quadrilateral to approximate the
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vessel works well and you can expect to get an accurate value for the length of
the vessel; however, when a vessel becomes more tortuous (Figure 18), a
quadrilateral estimation isn’t as accurate. I expected this would only be a problem
with vessel lengths as the diameters are always a straight measurement. When
looking at the samples it seemed as tortuosity went down the higher you went in
vessel order, yet surprisingly, the only difference came in order 5 vessels, and I
think the only reason for that is the sample size, which was 35 order 5 vessels.
Since the program is measuring straight lines for curving vessels, the length
measurements are always going to be shorter than actual measurements, but

Figure 18 – Using the automation tool will approximate a vessels length if it is
curved. The program output a length of 76.52μm, while the manual measurement
output 123.01μm, which is a 37.79% difference.
statistically, this only makes a difference for order 5 vessels. Therefore, if this
program is used to substitute manual measurements, order 5 lengths should still
be measured manually.
The major advantage to this program is one of organization, which leads
to efficiency. When four points are selected and a rectangle is drawn and
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measured, the rectangle outlining the vessel remains as a marker for which
vessels have been measured already (Figure 14). This doesn’t happen when
using the manual measurement technique, so remembering which vessels have
been measured becomes challenging. The macro also groups length and
diameter into one measurement output, rather than manually measuring the
length and the diameter in two different measurements.
Conversely, one difficulty with the macro is still the time it requires to make
a measurement. Hovering over four different points and clicking a button on a
keyboard to define thousands of vessels still takes a lot of time. The macro is a
step in the right direction, but there are still improvements to be made that could
save more time. Another issue is measuring the lengths of level 5 vessels. Since
there are a low amount of level 5 vessels per sample an easy solution is to
switch to manual measurement. Human error is another issue, since both
methods require a user to define a vessel; some variance will always be present.
The percent differences seen in Table 2 demonstrate that even with simple
samples it’s hard to define the same start and end for the manual and macro
techniques; however, this small of a variance is unlikely to have any effect on the
morphometry.
The initial logic for the development of the macro required the macro to
wait for 4 clicks from the user, sort the points, draw the correct quadrilateral, and
then make the calculations and output. However, limited programing abilities
required adjusting the initial logic while still obtaining the desired output. For
example, using the “getCursorLoc” command (meant to pick points when user
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clicked the left mouse button) was really hard to work with and picked up left and
right clicks, click releases, and rollovers. Searching online discussion forums I
came across the use of a “hot key” to label points instead of a mouse click;
implementing this method eliminated the “getCursorLoc” issues, and instead of 4
mouse clicks, required the user to hover over the point of interest and press the
letter “a” to define a point. Problems also arose when trying to create a “sort”
function to order input selections from the user correctly, but was solved by
requiring the user to select their points in the following order: upper left, upper
right, lower left, and then lower right. The input always comes in the same order
so the calculations are performed correctly. Output was another issue; initially the
program output the values as one single column and exporting it to excel placed
all of the data into cell A1 instead of individual cells. Updating the code to a new
multi-column format and adding commas after each data point so that excel
could use them as a delimiter allowed for excel import into separate cells, in 7
columns. Slight deviations were taken from the initial design criteria; however,
the final macro accomplished the goal of recording length and diameter values
with one measurement.
This program is a good starting point to progress away from manual
measurement but it is still relatively basic, and numerous features could be
added to optimize morphological measurement. Currently, it gathers data from
four clicks to output the same length and diameter measurements as the manual
method, all things being equal. Ideally, the program would gather all of the
desired morphological measurements. As stated earlier, an artificial intelligence
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algorithm could solve this problem by scanning the sample and through pixel
recognition decide whether a pixel is “vessel” or “not vessel”. This would be done
throughout the image until the program has a data-driven image of the vascular
system, which it would use to compute the morphology values. This level of
automation is achievable but requires intensive knowledge of algorithm
development in image recognition and a high number of samples to test for
algorithm augmentation. A more feasible next step for our lab would be to
integrate branch angle measurement into the macro. A simple addition would use
the ImageJ angle measurement tool and mark which angles have already been
measured. A more elegant addition would store every defined vessel as its own
element, then the user could select two adjacent elements and the program
would calculate the branch angle between them.
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Chapter 4 – The Impact of Collateral Enlargement on Transverse Arteriolar
Tree Structure
Introduction
After creating a successful vascular casting protocol using Microfil and a
measurement automation program, the next step was to gather morphological
data on a remodeled vascular network following arterial occlusion. PAD is
caused by insufficient blood flow to a tissue, which is usually induced by
atherosclerotic lesions that produce increased resistance and decreased blood
flow to the distal tissue, sometimes completely occluding an artery (20, 37). PAD
has many factors that can contribute to the pathophysiology, which is why a
ligated model was used to replicate an arterial occlusion in order to examine the
impact collateral enlargement has on transverse arteriolar tree structure.
The goal of this model is to induce blood flow changes and repair
processes that we can relate to PAD. Blood that previously flowed through the
femoral and saphenous arteries will mainly be rerouted through the deep femoral
and profunda femoris (34). Essentially, there are no more large arteries to feed
the distal hindlimb following ligation; this causes an increase in flow as oxygen
and other nutrients are rerouted through the gracilis collateral flow path to reach
the lower limb. The downstream tissues experience hypoxia and inflammation in
the lower leg, which promote angiogenesis (34). The ligation also causes an
increase in wall shear stress through the collateral vessels from the elevated
blood flow, which will result in the activation of endothelial nitric oxide synthase
(eNOS) to produce NO to cause vasodilation (25). The immediate effects of the
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increased shear stress will cause vasodilation due to the blood flow divergence,
while the chronic increase of shear stress will induce arteriogenesis (4, 43, 44).
Therefore, we can expect to see the collateral arteries that feed the gracilis
muscle to outwardly remodel in order to provide the blood flow needed for
recovery of the hindlimb (6, 7). The next step becomes investigating if the
increased flow and shear stress in the collateral results in a change in the
transverse arteriole (vessel order 4 and 5) networks branching off. This is
important for a few reasons: the presence of collaterals is a decent indication of a
patient with ischemic disease so stimulating arteriogenesis in these collaterals
could be used as a therapy for PAD. However, it is unknown how arteriogenesis
affects the microcirculation in the muscle housing the enlarged collateral and
since the microcirculation is critical to nutrient and waste exchange, changes
could affect muscle functionality. On one hand the increased flow could lead to
architecture and vessel expansion, and on the other, the increase of pressure
could lead to regression. This study could help determine if stimulating
arteriogenesis could be a concern because of the possibility of compromised flow,
and therefore, functionality, in the collateral-containing muscle.

Materials and Methods
Ligation Surgery
All protocols were approved by the Institutional Animal Care and Use
Committee. Eight C57BL/6 mice were used as the experimental group and had a
ligation tied around their left femoral artery just distal to the profunda femoris,
while a sham surgery was performed on their right leg. The surgeries were
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performed under aseptic conditions and using isoflurane anesthesia. Prior to the
procedure each animal was prepared by removing the hair over the surgical area
with clippers and depilatory cream and then disinfecting the area with Nolvasan.
The mice were maintained at 35±1.0°C using a rectal-temperature controlled
heating pad. The initial incision was made on the medial aspect of the hindlimb,
directly above the femoral neurovascular bundle, and was extended upwards to
the abdominal wall and downwards towards the origin of the saphenous artery,
making sure to keep the incision over the neurovascular bundle. Sterile saline
solution was used to irrigate the tissue and prevent muscle desiccation.
Connective tissue was blunt dissected to increase exposure. Following
connective tissue removal the epigastric fat pad was removed by heat cautery to
expose a site for the ligation just downstream to the profunda femoris. At the
chosen spot for ligation the nerve was carefully blunt dissected away from the
femoral artery, and then the vein was separated from the femoral artery in a
similar fashion. To ligate, 6.0 silk suture was used; following ligation, the skin
incision was closed with 7.0 polypropylene suture.
The sham surgery procedure included an incision above the femoral
neurovascular bundle. Sterile saline was used to irrigate and prevent tissue
desiccation while connective tissue was blunt dissected. Special care was taken
not to contact the neurovascular bundle in order to simulate every aspect of the
ligation except the vascular insult. Finally, the skin incision was closed with 7.0
polypropylene suture. The mouse then received a subcutaneous injection of
buprenorphine (0.075 mg/kg) and was allowed to recover on a hot pad until
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ambulatory (Appendix K). Mice were then returned to the Cal Poly vivarium for 2
weeks before the vascular casting procedure.
The Cal Poly vivarium is maintained at 73±5.0°F and lights are on a 12
hour light-dark cycle. Each micro-isolator cage houses no more than 4 mice and
is changed at least once per week. Mice are provided food and water ad libitum,
in addition to the following enrichments: mouse house, nesting material, and a
plastic tube. During cage changes, lab members wore isolation outfits that
included: full gown, gloves, face mask, bonnet, and booties to preserve aseptic
conditions. Further, mice were monitored on a daily basis, during which their
health and any irregularities were recorded and/or addressed as necessary.

Imaging
Sample images were taken using a QImaging Retiga EXi camera at 4x
magnification on an Olympus BX41 microscope using bright field microscopy
(Figure 19). QCapture Pro was used to capture the images after adjusting for
maximum contrast. Because of the size of the gracilis and the level of resolution
needed for morphological measurements, multiple images of the sample were
taken and then stitched together into a photomontage using the photomerge
function in Adobe Photoshop CS3 (Appendix M).
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A

B

Figure 19 – Bright field microscopy setup. A) QImaging Retiga EXi
camera. B) Olympus BX41 microscope.

Manual Measurement using ImageJ
Before measuring morphological parameters in a sample, branching order
was determined using the Strahler method. Strahler ordering begins by defining
the terminal branches of a given circulation. The terminal branches were
assigned 1. When two vessels of equal order come together (i.e. order n) at a
node or branch point, the parent vessel is assigned the next highest order, i.e.
n+1 (Figure 20A). When two vessels of unequal order come together at a node
or branch point (i.e. order n and n-2), the parent vessel is labeled order n (Figure
20B). Once all vessels were ordered morphological measurements were
obtained using the macro (described in chapter 3) or by manual methods
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(Appendix L) and vessel counts were gathered from the total diameter
measurements.

Figure 20 – A) When two vessels of order n meet, the parent vessel is
defined as order n+1. B) When a vessel of order n and a vessel of order n-1
meet, the parent vessel is labeled an order n.

Statistical Analysis
JMP was the software packaged used for the statistical analysis. The
experiment aimed to answer two questions: 1) does the sham surgery accurately
reflect the true control, and 2) is there a difference in vessel morphology in the
transverse arteriolar trees between the ligated and non-ligated samples? The
answer to the first question determined whether the ligated limbs were compared
to the sham limbs or to the true control limbs i.e. the samples from Chapter 2,
where only a vascular cast was performed without surgical intervention. Before
the statistical analysis, each sample was organized and measured. Each sample
was ordered (Figure 20) and if a sample didn’t have order 5 vessels it was
labeled as a poor cast and the data was excluded from the statistical analysis. Of
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the 32 total samples 9 were labeled as poor fills. Once the sample was ordered,
each ordered vessel’s length and diameter was recorded and averaged so that
for a given sample there was an average length and diameter for each individual
order. Order 6 diameter values were taken from 5 measurements along the
longitudinal arteriole, from the saphenous artery to the profunda femoris, which
were then averaged. Order 6 length measurements were not taken. Because
there were multiple orders and therefore multiple measurements per sample a
repeated measures analysis was performed in JMP (Appendix J); statistical
significance (p<0.05) between each condition was assessed using the TukeyKramer test (Appendix I). When comparing sham legs to ligated legs, a block
was placed on the mouse to eliminate mouse-to-mouse variability within the
results. Statistical significance of vessel counts (p<0.05) between the two
treatments across each order was assessed using t-tests (Appendix N).
Results
From the eight ligated mice, replicates C and H were labeled as a poor
casts and were excluded from analysis. From the true controls, replicates A, C
and the right leg from H were excluded (Appendix F). Figure 21 depicts a
successful vascular cast on a ligated animal.
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A

B
Figure 21 – Ligated animal E. A) Right leg – Sham surgery. B)
Left leg – Ligated.

Average lengths and diameters from the samples (Appendix G) were
used to calculate the least square means for each order. The right leg values
from the ligated animals (sham) were compared to the right leg values from the
animals only casted using Microfil (true control) to examine if the sham surgery
was an appropriate estimation of normal. Comparing control and sham found a
significant difference in the order 5 for length measurements (Figure 22A). No
significant differences were found between sham and control for diameter
measurements (Figure 22B). Comparing vessel counts between treatments
across each order showed no significant differences (Figure 23A); there was
also no significant differences between sham and ligated legs for length
measurements (Figure 23B). Comparing sham and ligated legs for diameter
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measurements found a significant difference in the order 6 measurements
(Figure 23C).

A

B
Figure 22 – Right legs (sham) of the ligated mice compared to
the right legs of the control mice (Microfil only). A) Length
measurements – significance found between control and sham
at order 5 only. B) Diameter measurements – no significance
found between any orders
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Figure 23 – Right legs of ligated mice (sham) compared to the left legs of ligated
mice (ligated). A) Vessel counts – no significance found. B) Length measurements
– no significance found. C) Diameter measurements – significance found between
sham and ligated legs at order 6 only.
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Discussion
Many factors contribute to the pathophysiology of PAD (46); therefore, a
mouse model was used to model one aspect of the pathology: an arterial
occlusion. The occlusion offered an increase in blood flow to the collateral circuit
in order to examine whether arteriogenesis impacts the transverse arteriole
architecture branching from the collateral. This could allow a better
understanding into how therapies to stimulate arteriogenesis would impact the
microvasculature and tissue function.
Comparing the sham surgery versus the right leg of the true controls
yielded a significant difference between the lengths of the order 5 vessels, with
the sham lengths being significantly greater than the control lengths. Although we
see this difference in the order 5 lengths of the sham and control samples, this
alone is not enough to say that the sham surgery cannot be used to estimate the
true control. Poiseuille’s law states that, all else being equal, an increase in
length will result in a decrease in volumetric flow. However, the length is not as
powerful of a factor as the radius of the vessel and there aren’t any significant
differences in the order 5 or even the order 6 diameters. This difference in length
is likely not a reflection of differences in the underlying biology, but rather a
reflection of insufficient replicates and therefore the sham can be used as a
control and simply opening the animal for surgery will not cause any significant
vessel remodeling for our purposes.
Comparing the sham leg to the ligated leg yielded a significant difference
between the diameters of the order 6 vessels. To reiterate, the order 6 vessels
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refer to the collateral arteriole that runs from the profunda femoris to the
saphenous artery. Arteriogenesis in this vessel is well-described (16), and is
induced by the elevated flow (shear stress) that is resultant of an increased
pressure gradient across the collateral vessel following ligation. Increased sheer
stress is a trigger for increases in arterial diameter and outward remodeling of the
arterial wall will occur to normalize the hemodynamic shear stress (4, 19, 38). So,
one reason why the elevated flow didn’t alter transverse arteriolar architecture is
because the increased hemodynamic shear stress caused by the ligation had
dissipated by the time the transverse arteriolar level was reached due to the
arteriogenesis seen in the collaterals. Another explanation could be due to
cellular communication between gap junctions that override the hemodynamic
stimuli and cause the network to remain relatively unchanged. Therefore, it’s
possible that stimulating arteriogenesis in a clinical environment should not
cause any negative effects in the collateral-containing muscle. However, this
observation is potentially limited by the differences between the ligation model
and a patient.
The femoral artery ligation model is a simplified model of a patient with
PAD (it only simulates an occlusion), which is why it’s important to understand
the differences between the model and PAD. One of the main differences is the
cause for the conditions, which are significantly different. When the femoral
artery is ligated, the arterial occlusion occurs quickly, as the suture is pulled taut.
In the case of a patient with PAD, occlusion occurs as a result of atherosclerosis,
which occurs gradually as the build-up of plaque causes the narrowing of the
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arteries over many years (46), however, when a thrombus forms, partial
occlusion transitions to complete occlusion rapidly. In patients with PAD,
complete occlusion of arteries often results in limb necrosis without proper
treatment (10-40% have primary amputations and there is a mortality rate of 4070% in 5 years) (14). Further, humans with PAD typically present with other comorbidities like heart disease or obesity and have a gradual arterial narrowing
due to atherosclerosis at multiple vascular sites throughout the body (46). It is
likely that these co-morbidities explain the lack of revascularization. This results
in a slower impairment of blood flow and progression of hypoxia and could alter
the mechanisms for vascular repair (46). Conversely, in the mouse, hindlimb
revascularization occurs and the mouse is able to recover over a period of 2-4
weeks sans intervention or treatment (34). The ligation model results in an
arterial occlusion at one point, so, while both PAD and the model induce an
occlusion in the extremities and hindlimb, respectively, the mechanisms are
different. It is important to be aware of these differences as one interprets
experimental results and makes conclusions regarding the process of
revascularization and how it may influence recovery of vascular function following
arterial occlusion when using a mouse model.
Interesting future experiments could gather branch angle measurements
to add to the analysis. Further, flow measurements could be taken for the whole
muscle to examine the impact of architecture versus reactivity or experiments
could examine the impact architecture has on vasodilation. Future applications of
this research could try to address one of the major concerns with therapeutic
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angiogenesis: tumor-like microcirculation. Previous experiments delivering basic
FGF or VEGF developed stable vascular networks; however, they soon began to
resemble immature tumor vasculature (11, 14). It’s important to understand why
that happened by better understanding the network repair process. This study
examined the repair process in a simple animal model, so the next step would
either be to examine different muscles in a hypoxic area or to deliver growth
factors and see how the network changes, which could eventually lead to finding
what morphology values differentiate a healthy network from a tumor network
and how a network can be prevented from diverging from stable to tumor-like.
Other experiments would examine the role of gap junction communication in
network remodeling by performing similar experiments in connexin knockout
mice.
Before proceeding with future experiments it would be advantageous to
investigate new methods to make data collection more efficient. Measuring the
samples requires a high level of resolution for order 1 vessels; 15-25
photomicrographs must be captured and then montaged, sometimes manually.
Ideally, a high-resolution camera would capture a full sample image with enough
detail that measurement of order 1 vessels is possible. High resolution cameras
capable of this task exist but are available in the $40,000 range. A more plausible
solution would be to capture up-close representative images. This would require
identification of the large transverse arteriole trees that reach order 5 vessels;
these arteriole trees would be ordered and measured and would give a sufficient
representation of the vascular network. Of the samples prepared there were
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between two and five of these arteriole trees per sample, on average. Capturing
only the large transverse trees would decrease the images needed from between
15 and 25 for an entire sample to between 5 and 15 to capture the chosen trees.
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Chapter 5 - Discussion
Previous studies have revealed the complexity of vascular remodeling (19,
31, 38) and relatively simple treatments in clinical trials have yielded less than
optimal results (11, 14). In order for therapeutic angiogenesis to be successful,
there needs to be a more comprehensive understanding of the vascular growth
process to understand why therapeutic angiogenesis was unsuccessful in clinical
trials. A more complete understanding of the effects of revascularization on
vascular network topology could provide information to devise more efficacious
therapeutic angiogenesis treatments for patients with PAD.
The overall objectives of this study were to establish procedures to
increase the efficiency of microvascular network morphology and use these
procedures to investigate microvascular remodeling following arteriogenesis.
The aims for the thesis were as follows:
1) Create a vascular casting protocol to only cast the arterial side of the
microcirculation.
2) Decrease the time to measure microvascular morphology through some
form of automation.
3) Determine the impact of collateral artery enlargement on the topology of
arteriolar networks that branch from the collateral artery.
Through Aim 1, I developed a vascular casting protocol to only cast the
arterial side of the microcirculation with the commercially available casting
compound Microfil. This protocol required an adjustment of the Microfil viscosity.
The ideal mixture for casting the arterial side was a ratio of X MV-122 to Y of
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both the high and normal viscosity diluent (as long as Microfil was prevented
from entering the lower leg A-V shunt). Because this was successful, the venous
side no longer complicated the image; this allowed for a more thorough vessel
identification of arterial trees, trees that were previously lost among the confusion
of India ink casting were now measurable. When ordering an India ink cast it is
difficult to discern between arteries and veins, especially for lower ordered
vessels. This leaves the user to select arterial trees that were easy to identify.
This results in much lower vessel numbers than the Microfil casting technique.
Since Microfil casting makes it much easier to identify arterial vessels, more
vessels were measured (Appendix H) and, therefore, more time was required for
data collection. Future modifications could order the entire sample and then only
measure the arteriole trees that reach order 5 before connecting back to the
longitudinal arteriole. This aim only examined the gracilis, but future work could
adapt the protocol to include other muscles like the spinotrapezius, and it could
even be adjusted to fill less of the arterial circulation, depending on the branching
order of interest.
Through Aim 2 I decreased the time for morphological measurement of
the anterior gracilis with a macro written in ImageJ. For this procedure, the vessel
is defined with four clicks; the macro creates a quadrilateral with the points and
then measures the two lengths and diameter values to output an average length
and diameter for the selected vessel. Conversely, manual measurement requires
separate length and diameter measurements. Surprisingly, results found that the
macro’s estimation of length was only significantly different for order 5 vessels,
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where the sample size was small. Overall, the macro is a first step in making
morphometry measurements more efficient. The next iteration of the process
would add a vessel angle measurement to the macro, such that all three
measurements are bundled into one step. One of the unforeseen side effects of
the new vascular casting protocol was that because the venous vasculature was
un-casted, arterial vasculature was much easier to identify, which increased
vessel numbers significantly and therefore inadvertently increased the
measurement time. To maintain efficiency, focus should be kept on
measurement of well-casted vascular trees; meaning, after ordering a sample,
measurements should only be made in vascular trees that reach order 5 before
connecting back to the longitudinal arteriole.
For the 3rd and final aim, I used the casting procedure and morphology
macro, developed in Aims 1 & 2, to compare transverse arteriolar networks
branching from an enlarged collateral to transverse arteriolar networks branching
from a non-enlarged collateral. As expected the collateral arteriole (order 6) did
outwardly remodel. We expected that the increased flow and shear stress in the
collateral would impact the transverse arteriole networks branching from the
collateral. Surprisingly, there was no significant difference for any diameters,
lengths, or vessel numbers for orders 1 – 5, indicating that the networks aren’t
significantly changing. This could be due to the lack of hemodynamic shear
stress (absorbed by the outward remodeling of the collateral arteries), which
would cause outward remodeling or it could be due to cell-to-cell communication
through gap junctions overriding the hemodynamic stimuli.
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It is important to note that using Microfil as a casting agent doesn’t
completely eliminate issues arising with discerning vessels for measurement.
Complex vessel branching patterns necessitate subjective measurement of multidirectional networks that frequently overlap and intertwine. The gracilis muscle is
also three-dimensional, so any vessels in the z-direction may not be measured
accurately, however, since the gracilis is relatively flat, this likely didn’t impact on
results. Another issue identifying vessels stems from inconsistent dissecting of
the gracilis muscle that leaves some samples with other muscles that underlie
the gracilis and add layers of vessels that are unwanted.
Overall, pairing the new Microfil casting technique with the photomerge
stitching functionality in Photoshop yields an image that shows the larger picture
of vascular structure following an arterial occlusion. Furthermore, because of the
high resolution of the images, one is able to make measurements of lower order
vessels to gather data to explore changes in the vascular structure. The ligation
model experiments demonstrated functionality of the new techniques and laid the
groundwork for further experiments to be performed where vascular topology is
examined rather than vessel cross-sections for the development of PAD
treatments. Ultimately, more thorough analysis of microvascular network
topology following arterial occlusion should assist in the development of
successful therapeutic angiogenesis treatments for patients with PAD.
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Appendix A
The following are the true control samples. ACRNI is a full sample label where
“AC” denotes control animal a, “R” denotes right leg, and “NI” denotes nonischemic.

ACLNI

ACRNI

BCLNI

BCRNI
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CCLNI

CCRNI

DCLNI

DCRNI
73

ECLNI

ECRNI

FCLNI

FCRNI
74

GCLNI

GCRNI

HCLNI

HCRNI
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Appendix B – Microfil casting and dissection protocol
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Appendix C – Program code – Logic comments are displayed in green
var loc = newArray(0,0,0,0, 0,0,0,0);
var count = 0;
var tot = 1;
macro "Sample Tool [a]" {
% Prints correct headers
if (tot == 1 && count == 0) {
print("Pol #,H1 (um),W1 (um),H2 (um),W2 (um),AvgH (um),AvgW (um)");
}
% gets x,y,z coordinates on cursor location when “a” is clicked
getCursorLoc(x, y, z, flags);
loc[count] = x;
loc[count + 1] = y;
makePoint(x, y);
setForegroundColor(0, 0, 0);
run("Draw");
count = count + 2;
if(count > 7) {
calc();
count = 0;
}
}
% Allows user to undo a mistake by pressing “y”
macro "Clear [y]" {
while (count > 0) {
run("Undo");
count -= 2;
}
}
% Uses 8 user defined values from 4 locations to calculate and print calibrated height and width
function calc() {
makePolygon(loc[0], loc[1], loc[2], loc[3], loc[6], loc[7], loc[4], loc[5]);
setForegroundColor(0, 0, 0);
run("Draw");
h1 = loc[5] - loc[1];
h2 = loc[7] - loc[3];
w1 = loc[2] - loc[0];
w2 = loc[6] - loc[4];
aveH = (h1 + h2) / 2;
aveW = (w1 + w2) / 2;
print(tot + "," + h1 / 0.575 + "," + w1 / 0.575 + "," + h2 / 0.575 + ","
+ w2 / 0.575 + "," + aveH / 0.575 + "," + aveW / 0.575);
tot++;
}
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Appendix D – How to use Automation Macro Protocol
To use the tool, first move the automation tool file “automation tool.ijm”
into ImageJ’s macros folder, most likely found at the path seen in figure A on the
following page. Next, run ImageJ and click to install a new macro (B). Find
“automation tool.ijm” and open it. Make sure the “point tool” is selected on the
ImageJ tool bar and define boxes around a vessel by clicking in the correct order
(C). Once every vessel has been defined and measured, open the text log and
save it (D). Next, open excel and choose to open a file; find the saved text log
from ImageJ (if the text log isn’t found change the file types in Open from “All
Excel Files” to “All Files”) (E). Upon arrival to the text import wizard; make sure
“delimited” is checked on the first page (F) and that “tab” is checked on the
second page (G) and then click finish to get the results in an excel format (H).
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The steps to install and run the automation tool. A) The most common
location of the ImageJ macros folder where the “automation tool.ijm” file
should be copied. B) How to install a new macro. C) The correct click order to
define a vessel for measurement. D) The log file of measurements that must
be saved in order to export to excel. E) Select “all files” in order to open your
log file in excel. F) Import screen 1 – make sure delimited is checked. G)
Import screen 2 – make sure comma is checked. H) Example of final Excel
output.
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Appendix E – Macro versus Manual statistical comparison
Repeated measures analysis setup in JMP (this window can be accessed in JMP
by going to Analyze>Fit Model in the toolbar) and Tukey-Kramer results.

A

B

Tukey-Kramer Results – A) Diameters B) Lengths
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Appendix F – Ligated Animal Vascular Casts (NI – Sham Surgery, I –
Ischemic/Ligated)

ALI

ARNI

BLI

BRNI
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CLI

CRNI

DLI

DRNI
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ELI

ERNI

FLI

FRNI
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GLI

GRNI

HLI

HRNI
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Appendix G – Averages of samples. Order 6 diameters were taken from 5
measurements along the longitudinal arteriole, from the saphenous artery to the
profunda femoris, which were then averaged. Order 6 length measurements
were not taken.
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Appendix H – Total Vessel Counts
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Appendix I – JMP output of Tukey-Kramer results for sham versus control
and sham versus ligated

Sham versus control - Length

Sham versus control - Diameter

Sham versus ligated - Length

Sham versus ligated - Diameter
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Appendix J – Statistical Setup in JMP for sham versus control and sham
versus ligated
The screen shots on the following page show how to set up a repeated
measures analysis in JMP. In the JMP home window access this screen by going
to Analyze>Fit Model. In the screen shots, behind the fit model window shows
how the data was organized. The Y variable is what is being measured; for this
analysis it was either vessel length or diameter. The construct model effects
window is where the different treatments, experimental units and effects are
placed for the correct analysis. A) The model fit for the sham versus control
length analysis. The treatment (sham or control) is nested within the mouse
variable because treatments were delivered across different mice. B) The model
fit for the sham versus ligated length analysis. Blocking on the mouse was done
to remove variability within the experiment because the treatment (sham or
ligation) was done on the same mouse. This is why the added “Mouse” variable
is seen in the construct model effects window as well as mouse being crossed
with treatment instead of being nested as before.
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A

B
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Appendix K – Femoral Artery Ligation Checklist
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Appendix L – Manual Measurement Protocol
1) Calibrate ImageJ (see figure A below)
2) Select the freehand lines tool (see figure B below) to trace the vessel
segments that need measuring.
3) Press <Ctrl+M> to measure the segment length. Note: Vessel length and
diameter need to be measured separately, and it’s easiest to measure a
vessels length, followed by the diameter, as opposed to measuring all the
lengths and then all the diameters, which makes it difficult to organize in
the results window. Measurements can then be copied into Excel to be
analyzed.

B

A
Steps to measure an image manually in ImageJ. A) How to set the
proper scale. B) How to select the freehand line for tracing a vessel.

92

Appendix M – Photoshop CS3 Photomerge Protocol
First, open all the files to photomerge, select the photomerge function from
the automate menu. Next, select all the files to be photomerged. Photomerge will
attempt to automatically arrange all the images into a single panorama. Because
of the intricacies of the vessels, photomerge sometimes fails at automatically
arranging the images. In this instance, manual arrangement is necessary. As a
check I would name my image files in order to make sure Photoshop arranged
them properly and for ease of manual arrangement.
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Appendix N – T-test statistical results for vessel count
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Appendix O – Image Permissions
Figure 4 permissions
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Figure 5 permissions
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